Dr. Mark R Albertini MD
Hematologist-Oncologist | Hematology & Oncology
600 Highland Ave Madison WI, 53792About
Dr. Mark Albertini is a hematologist oncologist practicing in Madison, WI. Dr. Albertini specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ of Vt Coll of Med, Burlington Vt 1984
University of Vermont College of Medicine 1984
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Dermatomyositis after interferon alpha treatment.
- Antigenicity of human melanoma cells transfected to express the B7-1 co-stimulatory molecule (CD80) varies with the level of B7-1 expression.
- Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2.
- In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood
- Donor-derived small cell lung carcinoma in a kidney transplant recipient.
- Localization of transfected B7-1 (CD80) DNA in human melanoma cells after particle-mediated gene transfer.
- Preclinical and clinical development of immunocytokines.
- Phase II trial of weekly paclitaxel in patients with advanced melanoma.
- Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma.
- Hydrodynamic limb vein delivery of a xenogeneic DNA cancer vaccine effectively induces antitumor immunity.
- A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients.
- Intratumoral injection of IL-12 plasmid DNA--results of a phase I/IB clinical trial.
- A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.
- Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.
- Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.
Treatments
- Prostate Cancer
- Melanoma
- Skin Cancer
- Lung Cancer
- Colon Cancer
Dr. Mark R Albertini MD's Practice location
Dr. Mark R Albertini MD's reviews
Write ReviewRecommended Articles
- Exercise Proven to Help Lymphoma Patients
People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...
- The Link Between Lymphoma Radiotherapy and Mesothelioma
One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- The Blow Self-Image Can Take During Lymphoma Treatment
Many who have endured cancer treatment experience a blow to their self image, and cease to recognize the person looking back at them in the mirror.However, it does not have to be that way! Here are some of the most common changes, and how to cope with them.Skin changesYou may begin to see your skin...
- Survey Shows Lack of Blood Cancer Knowledge Among Americans
If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
Nearby Providers
- Dr. Thomas A Mcfarland MD1 S Park St Madison WI 53715
- Dr. Michael S Huie MD1 S Park St Madison WI 53715
- Dr. Anne M Traynor MD600 Highland Ave Madison WI 53792
- Dr. Shannon E O'mahar MD1200 John Q Hammons Dr Madison WI 53717
- Dr. Lisa M. Lepeak M.D.1200 John Q Hammons Dr Madison WI 53717
- Dr. Natalie S Callander MD600 Highland Ave Madison WI 53792